Striae in Adult
Alerts and Notices
Important News & Links
Synopsis

Striae (striae distensae), or stretch marks, are common in all ages due to thinning or atrophic defects in the dermis, typically in areas of repeated or prolonged skin stretching. The etiology likely involves the interplay of mechanical stress, hormones, and genetics. Striae are commonly located on the abdomen, thighs, and buttocks, or in areas where the skin stretches excessively. Striae are slightly more common in light skin phototypes and are twice as common in females.
Periods of rapid growth, such as puberty, pregnancy (striae gravidarum), training with weight lifting, rapid weight gain, and adolescent growth spurts, are common triggers. Striae also commonly occur in the setting of obesity. As 60%-70% of the US population is labeled as overweight or obese, the prevalence of striae from obesity is estimated at 40%. The skin findings themselves are rarely symptomatic, but they may occasionally indicate an underlying disease state (such as Cushing syndrome). In Marfan syndrome, striae are seen in around two-thirds of patients. Striae tend to flatten and become less conspicuous over time.
Bevacizumab, a vascular endothelial growth factor (VEGF) inhibitor, has been reported to cause ulceration of striae that have been induced by concurrent systemic glucocorticoid therapy.
Related topic: drug-induced skin ulcers
Periods of rapid growth, such as puberty, pregnancy (striae gravidarum), training with weight lifting, rapid weight gain, and adolescent growth spurts, are common triggers. Striae also commonly occur in the setting of obesity. As 60%-70% of the US population is labeled as overweight or obese, the prevalence of striae from obesity is estimated at 40%. The skin findings themselves are rarely symptomatic, but they may occasionally indicate an underlying disease state (such as Cushing syndrome). In Marfan syndrome, striae are seen in around two-thirds of patients. Striae tend to flatten and become less conspicuous over time.
Bevacizumab, a vascular endothelial growth factor (VEGF) inhibitor, has been reported to cause ulceration of striae that have been induced by concurrent systemic glucocorticoid therapy.
Related topic: drug-induced skin ulcers
Codes
ICD10CM:
L90.6 – Striae atrophicae
SNOMEDCT:
201066002 – Skin striae
L90.6 – Striae atrophicae
SNOMEDCT:
201066002 – Skin striae
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
- Anetoderma is caused by focal loss of elastic fibers within the dermis and presents as flaccid, well-circumscribed areas of slack skin. Sac-like protrusions can occasionally be observed in some lesions.
- Lichen sclerosus presents as flat, yellowish-white plaques surrounded by a red, purple, or violet border.
- Steroid atrophy may accompany striae caused by topical corticosteroids.
- Scars are raised, firm nodules or plaques at sites of previous trauma.
- Linear focal elastosis (elastotic striae) is a rare condition that presents as asymptomatic atrophic yellow lines on the mid- or lower back, thighs, arms, or breasts.
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
Drug Reaction Data
Below is a list of drugs with literature evidence indicating an adverse association with this diagnosis. The list is continually updated through ongoing research and new medication approvals. Click on Citations to sort by number of citations or click on Medication to sort the medications alphabetically.
Subscription Required
References
Subscription Required
Last Reviewed:09/22/2019
Last Updated:09/17/2020
Last Updated:09/17/2020

Premium Feature
VisualDx Patient Handouts
Available in the Elite package
- Improve treatment compliance
- Reduce after-hours questions
- Increase patient engagement and satisfaction
- Written in clear, easy-to-understand language. No confusing jargon.
- Available in English and Spanish
- Print out or email directly to your patient
Upgrade Today